Kritchevsky D
J Environ Pathol Toxicol Oncol. 1986 Mar-Apr;6(3-4):273-84.
Dietary fiber has been, for several years, the glamour ingredient in popular nutrition. Based on epidemiological evidence, lack of fiber in the diet has been impugned as a major risk factor for development of colon cancer, heart disease, diabetes and a variety of lesser ills. Animal experiments suggest that some components of the complex mixture of substances called fiber will reduce cholesterol levels to a modest extent and will inhibit atherosclerosis induced by diet. In man the data center on the effects of fiber on plasma cholesterol levels and some fibers such as pectin or guar exert significant hypocholesterolemic effects whereas others, such as bran, do not. The situation is similar with regard to colon cancer. Some types of fiber, bran and cellulose for instance, inhibit experimentally induced colon cancer. There are a number of ways of establishing experimental colon cancer; feeding the carcinogenic agent, injecting it, or instilling it intrarectally. There also exists a variety of carcinogenic agents. The effect of fiber is the sum of the type of fiber and carcinogen used and the mode of establishing the cancer. Different combinations give different results in animal studies. In man the data bearing on this subject are wholly epidemiological. A few case-control studies have provided suggestions that low fiber diets may predispose to colon cancer but these studies point to a dietary life-style in which many components other than fiber vary. The most notable success in wedding practice to hypothesis has been in the area of diabetes. Here it has been shown clearly that increasing dietary fiber results in reductions in lipemia, glycemia and insulin requirement. What remains? More work in the cancer and heart disease fields but mainly a greater effort to identify the specific structure of those fibers which exert a beneficial effect. This will have the two-fold benefit of identification of specifically useful structural types of fiber and of possibly providing clues to mechanism of action or of carcinogenicity. Most experts agree that a modest increase in intake of fiber will have a generally beneficial effect but they can only support these statements with epidemiological proof. Future research must include studies designed to confirm the epidemiological findings and to identify the specific components responsible for them.
多年来,膳食纤维一直是大众营养领域备受瞩目的成分。基于流行病学证据,饮食中缺乏纤维被指责为结肠癌、心脏病、糖尿病以及各种较轻疾病发生的主要风险因素。动物实验表明,被称为纤维的复杂物质混合物中的某些成分会在一定程度上降低胆固醇水平,并抑制由饮食引起的动脉粥样硬化。在人类中,数据集中在纤维对血浆胆固醇水平的影响上,一些纤维,如果胶或瓜尔豆胶,具有显著的降胆固醇作用,而其他纤维,如麸皮,则没有。结肠癌方面的情况类似。某些类型的纤维,例如麸皮和纤维素,可抑制实验诱导的结肠癌。建立实验性结肠癌有多种方法;喂食致癌剂、注射致癌剂或经直肠注入致癌剂。也存在多种致癌剂。纤维的作用是所用纤维类型和致癌剂以及建立癌症的方式的综合结果。在动物研究中,不同的组合会产生不同的结果。在人类中,关于这个主题的数据完全是流行病学的。一些病例对照研究表明,低纤维饮食可能易患结肠癌,但这些研究指向的是一种饮食生活方式,其中除纤维外的许多成分也各不相同。将实践与假设相结合最显著的成功案例发生在糖尿病领域。在这里,已经清楚地表明,增加膳食纤维摄入量会导致血脂、血糖和胰岛素需求量降低。还剩下什么呢?在癌症和心脏病领域需要开展更多工作,但主要是要更加努力地确定那些具有有益作用的纤维的具体结构。这将带来双重好处,既可以识别出特别有用的纤维结构类型,又可能为作用机制或致癌性提供线索。大多数专家一致认为,适度增加纤维摄入量通常会产生有益效果,但他们只能用流行病学证据来支持这些说法。未来的研究必须包括旨在证实流行病学研究结果并确定导致这些结果的具体成分的研究。